Gyre Therapeutics, Inc. GYRE Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable
Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s increase (decrease) in income taxes payable, net of income taxes receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s increase (decrease) in income taxes payable, net of income taxes receivable?
- Gyre Therapeutics, Inc. (GYRE) reported increase (decrease) in income taxes payable, net of income taxes receivable of $144K in Q1 2026.
- How has Gyre Therapeutics, Inc.'s increase (decrease) in income taxes payable, net of income taxes receivable changed year-over-year?
- Gyre Therapeutics, Inc.'s increase (decrease) in income taxes payable, net of income taxes receivable increased by 106.4% year-over-year, from -$2.27M to $144K.